Nick Paul Taylor

Biography for Nick Paul Taylor

Nick Taylor, UK Correspondent

Nick Taylor is a freelance journalist with more than six years' experience of reporting on the global biopharma industry. Since graduating with a biology degree from the University of York, Nick has written for numerous healthcare publications, including Nature BioPharma Dealmakers, Life Science Leader and Outsourcing-Pharma. You can contact him at and follow him on Twitter at @NickPaulTaylor.

Articles by Nick Paul Taylor

RainDance files for $60M IPO

RainDance Technologies has taken a step toward completing its long-planned IPO by filing the paperwork for a $60 million offering.

Pfizer: Our IT systems are subject to frequent attacks

Pfizer has updated the risk factors section of its U.S. Securities and Exchange Commission (SEC) filings to reflect the new normal in cybersecurity. The Big Pharma lays out the situation plainly: "As a global pharmaceutical company, our systems are subject to frequent attacks."

Analyst casts doubt on Big Data potential of Covance-LabCorp merger

LabCorp closed its $5.7 billion takeover of Covance this week and immediately began talking up the potential for its testing data to turbocharge the CRO's clinical trial business.

Eccrine bags seed funding for Air Force-developed sweat sensor

Eccrine Systems has raised $1.5 million in seed funding to develop a sweat sensor based on know-how that originated at the University of Cincinnati and the Air Force Research Labs. The Cincinnati, Ohio-based startup will use the cash to forge ahead with the development of wearable sensor technology it plans to pitch to clinical trial sponsors.

Novo Nordisk set to rake in up to $335M from IT unit IPO

Novo Nordisk has set the terms for the IPO of its IT services unit NNIT. If NNIT prices at the top end of its range when it goes public in the next week or so, the listing could generate up to $335 million for Novo Nordisk.

H3 hooks up with Foundation Medicine for data-driven oncology R&D

Foundation Medicine has followed up its transformational deal with Roche by inking an oncology alliance with Eisai-backed H3 Biomedicine. The deal sees Foundation Medicine pair its genomic database with H3's computational biology capabilities.

Big Data digging yields unprecedented road map of the epigenome

A massive data generation and analysis program has uncovered a map of the epigenome, the switches that turn genes off and on. Researchers published their findings in a series of papers in Nature and released the data for further analysis through the National Center for Biotechnology Information.

Epic preps app store to link new tools to EHR systems

Epic Systems is preparing to open an app store. The platform will allow software developers to create apps that connect to Epic's electronic health records system, the Wisconsin State Journal reports.

FDA puts cloud storage and Google-esque search tools on precision medicine road map

The FDA has outlined how it will spend the $10 million it is set to receive as part of President Obama's Precision Medicine Initiative. The road map includes full or hybrid cloud storage, open-source data sharing platforms and Google-esque search tools.

Transcriptic snags $8.5M to add capabilities at robot-run lab

Robot-run lab startup Transcriptic has raised $8.5 million in a Series A round to buy more equipment and expand its service offering. The round once again attracted a clutch of big name, Big Data-focused Silicon Valley VC funds, including Data Collective and IA Ventures.